Posted by Michael Wonder on 21 Jun 2023
MSAC publishes agenda for October 2023 ESC meeting
21 June 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC on 5-6 October 2023.
The agenda currently has 9 items. Applications of note include:
1690.1 – Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell to treat refractory or relapsed multiple myeloma
1723.1 – Brexucabtagene autoleucel for adult relapsed or refractory B-precursor acute lymphoblastic leukaemia
1740 – N-terminal-pro brain natriuretic peptide to aid in the diagnosis of patients with suspected heart failure in a non-hospital setting
